Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer

MLA

Chan Gyoo Kim, et al. “Helicobacter Pylori Therapy for the Prevention of Metachronous Gastric Cancer.” New England Journal of Medicine, vol. 378, Mar. 2018, pp. 1085–95. EBSCOhost, https://doi.org/10.1056/nejmoa1708423.

APA

Chan Gyoo Kim, Boram Park, Byung-Ho Nam, Jong Yeul Lee, Il Ju Choi, Young-Il Kim, Myeong Cherl Kook, & Soo-Jeong Cho. (2018). Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. New England Journal of Medicine, 378, 1085–1095. https://doi.org/10.1056/nejmoa1708423

Chicago

Chan Gyoo Kim, Boram Park, Byung-Ho Nam, Jong Yeul Lee, Il Ju Choi, Young-Il Kim, Myeong Cherl Kook, and Soo-Jeong Cho. 2018. “Helicobacter Pylori Therapy for the Prevention of Metachronous Gastric Cancer.” New England Journal of Medicine 378 (March): 1085–95. doi:10.1056/nejmoa1708423.